Experience in managing patients of reproductive age with dyshormonal diseases of the mammary glands

Authors

DOI:

https://doi.org/10.18370/2309-4117.2020.55.109-112

Keywords:

breast, mammary dysplasia, menstrual irregularities, indole-3-carbinol, Indole-F

Abstract

This article presents the results of own research of the Indol-F® efficacy and safety in the treatment of 86 patients of reproductive age with a dysplasia of mammary glands for 3 months. Comparison was carried out with 50 women who were under dynamic observation. Improvement of mammary glands status (by a set of attributes) on treatment with Indole-F® was observed in 75,6% of patients, menstrual function normalization in 63,3% of patients. At the same time, spontaneous progression of symptoms was noted in more than a half of patients in the observation group.

Author Biographies

S. A. Lasachko, Medical centre “Verum”, Kyiv

PhD

I. M. Shakalo, SI “O.M. Lukyanova IPOG of the NAMS of Ukraine”, Kyiv

PhD, junior researcher, Endocrine Gynecology Department

Published

2020-11-30

Issue

Section

Analytical review